Pancreatic lipase is a critical enzyme involved in the metabolism of lipids, and substances that inhibit its activity could potentially be useful in addressing obesity and hyperlipidemia [10]. Here, PNLIP is linked to obesity due to melanocortin 4 receptor deficiency.